말기신부전 환자의 수면장애와 심근손상 = Sleep Disturbance and Myocardial Damage in Patients with End-Stage Renal Disease

다국어 초록 (Multilingual Abstract)

Background:Recently, it was suggested that sleep disorders, like sleep apnea and periodic limb movements during sleep, are associated with the cardiovascular complications and outcomes seen in ESRD patients. This study investigated the association between sleep disturbances, including nocturnal hypoxemia, and myocardial damage in ESRD patients.
Methods:We conducted a cross-sectional study of 15 hemodialysis patients (age=50±8 years, M:F= 11:4, diabetes=6) who were classified as at high risk of sleep disturbance using the Epworth Sleepiness Scale and Sleep Disorders Questionnaire. Overnight polysomnographic studies were performed in these 15 patients to evaluate sleep parameters. The predialysis serum concentration of cardiac troponin T (cTnT) was measured as a marker of myocardial damage.
Results:Apnea＋hypopnea index >5, which is a diagnostic criterion of sleep-related breathing disorder, was found in 12 (80%) patients. Several sleep parameters were associated with cTnT concentration. Sleep efficiency and lowest oxygen saturation decreased (p<0.05 and p=0.06, respectively), and average desaturation increased (p<0.05) with increasing cTnT concentration. Spearman's Rho, which was used to assess the relationships between the severity of sleep apnea and clinical parameters, showed that apnea＋hypopnea index and oxygen desaturation index were negatively correlated (both p<0.01) with the serum concentration of uric acid. In multivariate analysis, the uric acid concentration was also independently associated with apnea＋hypopnea index and oxygen desaturation index.
Conclusion:Elevated concentration of cTnT was associated with poor sleep efficiency and severe oxygen desaturation during sleep, and the serum concentration of uric acid was lower in patients with severe sleep apnea.

국문 초록 (Abstract)

배 경:말기신부전 환자에서 수면무호흡증이나 수면중주기성하지운동증과 같은 수면장애들이 심혈관질환의 발생 및 예후와 연관되어 있을 가능성이 최근 제기되고 있다. 저자들은 말기신부전 환자에서 수면장애로 인한 저산소혈증 발생과 심근손상과의 관련성을 알아보고자 하였다.
방 법:유지 혈액투석 중인 환자 중 수면 설문조사인 Epworth Sleepiness Scale과 Sleep Disorders Questionnaire를 시행하여 수면장애 고위험군으로 분류된 15명의 환자 (연령=50±8세, 남:여=11:4, 당뇨=6명)를 대상으로 단면적 연구를 시행하였다. 야간수면다원검사를 시행하여 수면장애 지표들을 구하였고, 심근손상의 지표로서 cardiac troponin T (cTnT)의 혈청 농도를 측정하여 다음과 같은 결과를 얻었다.
결 과:수면호흡장애의 진단 기준인 무호흡＋저호흡지수 5회/시간 이상은 12명 (80%)의 환자에서 관찰되었다. 몇 가지 수면장애 지표들이 cTnT 농도와 관련이 있었다. cTnT 농도가 상승함에 따라 수면효율과 최저산소포화도는 감소하였고 (각각 p<0.05, p=0.06), 평균산소포화도감소량은 증가하였다 (p<0.05). Spearman 상관분석으로 수면무호흡증의 정도와 임상 지표들의 관계들을 분석하였을 때, 혈중 항산화제 중의 하나인 요산의 혈청 농도가 무호흡＋저호흡지수 및 산소포화도저하지수와 음의 상관관계 (둘 다 p<0.01)를 보였고, 다변량 분석에서도 요산 농도는 무호흡＋저호흡지수 및 산소포화도저하지수와 독립적으로 관련이 있었다.

참고문헌 (Reference)

1 "혈액투석 중인 만성 신부전증 환자에서의 불면증에 대한 연구" 6 : 126-132, 1999

2 "투석 받는 말기 신질환 환자의 수면장애" 21 : 492-497, 2003

3 "and stroke in relation to obstructive sleep apnea" 437-458, 1992

4 "The occurrence of sleep-disordered breathing among middle-aged adults" 328 : 1230-1235, 1993

5 "Sleep-related breathing diso rders impair quality of life in haemodialysis recipients" 17 : 1260-1265, 2002

6 "Sleep-disordered breathing and cardiovascular disease" 108 : 9-12, 2003

7 "Sleep apnea syndrome in chronic renal disease" 86 : 308-314, 1989

8 "Sleep apnea in renal failure" 13 : 88-92, 1997

9 "Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis" 56 : 1078-1083, 1999

10 "Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease" 106 : 2941-2945, 2002

11 "Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders" 35 : 1052-1060, 2000

12 "Obstructive sleep apnoea syndrome--an oxidative stress disorder" 7 : 35-51, 2003

13 "Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients" 13 : 729-733, 2002

14 "Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction" 36 : 959-969, 2000

15 "Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients" 19 : 287-293, 2001

16 "Evidence for lipid peroxida tion in obstructive sleep apnea" 27 : 123-128, 2004

17 "Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy" 162 : 566-570, 2000

18 "Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea" 107 : 68-73, 2003

19 "Creation and multivariate structure of SDQ" ni (ni): 160-167, 1994

20 "Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology" 46 : 338-344, 2000

21 "Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure" 113 : 1604-1608, 1998

22 "Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea" 348 : 1233-1241, 2003

23 "Cardiac troponins in renal insufficiency : review and clinical implications" 40 : 2065-2071, 2002

24 "Cardiac troponin T and malondialdehyde modified plasma lipids in haemodialysis patients" 18 : 737-742, 2003

25 "C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD" 9 : 621-630, 2000

26 "Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea" 122 : 829-839, 2002

27 "Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients" 16 : 70-77, 2001

28 "Antioxidant capacity in obstructive sleep apnea patients" 4 : 225-228, 2003

29 "A new method for measuring daytime sleepiness:the Epworth sleepiness scale" 14 : 540-545, 1991

30 "A manual of standardized terminology techniques and scoring system for sleep stages of human subjects" Public Health Service 1968

31 "A comparison of sleep-disordered respiration in ESRD patients receiving hemodialysis and peritoneal dialysis" 8 : 195-198, 1992

32 "=Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis" 290 : 353-359, 2003